Back to search

Article

Quinazoline-quinoline bisubstrate inhibitors target eukaryotic translation initiation factor 3 in <i>Plasmodium falciparum</i>

2022-12-11

Abstract excerpt

Malaria drug resistance is hampering the fight against the deadliest parasitic disease affecting over 200 million people worldwide. We recently developed quinoline-quinazoline-based inhibitors (as compound 70 ) as promising new antimalarials. Here we aimed to investigate their mechanism of action by using Thermal Proteome Profiling (TPP). The eukaryotic translation initiation factor 3 (EIF3i) subunit I was identi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
db0b3204-4b53-592a-b0bf-7908a334fdab
DOI
10.1101/2022.12.10.519887
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Quinazoline-quinoline bisubstrate inhibitors target eukaryotic translation initiation factor 3 in <i>Plasmodium falciparum</i>DOI 10.1101/2022.12.10.519887
Select a neighboring publication to make it the new centre.